Patents by Inventor Parthasaradhi Reddy Bandi

Parthasaradhi Reddy Bandi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS
    Publication number: 20230174570
    Abstract: The present invention relates to novel triterpene derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, n, and ring are as defined in formula (I). The invention also relates to novel triterpene derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Application
    Filed: February 11, 2021
    Publication date: June 8, 2023
    Inventors: Parthasaradhi Reddy BANDI, Rathnakar Reddy KURA, Panduranga Reddy ADULLA, Bhaskar Reddy KASIREDDY
  • Stable pharmaceutical product and vessel comprising sodium picosulfate, magnesium oxide and citric acid
    Patent number: 11471447
    Abstract: Described herein is a stable oral liquid pharmaceutical product comprising sodium picosulfate, magnesium oxide and citric acid. Particularly, sodium picosulfate is physically separated from magnesium oxide and citric acid prior to dispensing and is mixed at the time of administration.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: October 18, 2022
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Khadgapathi Podile, Sunil Deviprasad Tiwari, Vijay Nasare, Prakash Shetiya, Patchigolla Satyanarayana Rao, Chidara Ravi Chandra Gupta
  • NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS
    Publication number: 20220177439
    Abstract: The present invention relates to novel triterpene derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and ring are as defined herein. The invention also relates to novel triterpene derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Application
    Filed: February 11, 2020
    Publication date: June 9, 2022
    Inventors: Parthasaradhi Reddy BANDI, Rathnakar Reddy KURA, Panduranga Reddy ADULLA, Bhaskar Reddy KASIREDDY
  • NOVEL TRITERPENONE DERIVATIVES AS HIV INHIBITORS
    Publication number: 20220144882
    Abstract: The present invention relates to novel triterpenone derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined herein. The invention also relates to novel triterpenone derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Application
    Filed: February 11, 2020
    Publication date: May 12, 2022
    Inventors: Parthasaradhi Reddy BANDI, Rathnakar Reddy KURA, Panduranga Reddy ADULLA, V L Subrahmanyam LANKA
  • Anti-retroviral compositions
    Patent number: 11045423
    Abstract: The present invention relates to pharmaceutical antiretroviral compositions comprising a combination of antiretroviral agents (darunavir, dolutegravir and ritonavir), the manufacturing process thereof and use of the said compositions for the prevention, treatment or prophylaxis of HIV infection.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: June 29, 2021
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Khadgapathi Podile, Sunil Deviprasad Tiwari, Prakash Shetiya, Balakrishnaiah Medum
  • Stable bilayer tablet compositions
    Patent number: 11020351
    Abstract: The invention relates to stable bilayer tablet compositions comprising empagliflozin, linagliptin and pharmaceutically acceptable excipients which show no incompatibilities and the compositions having good stability and superior dissolution profile.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: June 1, 2021
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Khadgapathi Podile, Sunil Deviprasad Tiwari, Srinivasa Rao Gella
  • STABLE PHARMACEUTICAL PRODUCT AND VESSEL COMPRISING SODIUM PICOSULFATE, MAGNESIUM OXIDE AND CITRIC ACID
    Publication number: 20200397767
    Abstract: Described herein is a stable oral liquid pharmaceutical product comprising sodium picosulfate, magnesium oxide and citric acid. Particularly, sodium picosulfate is physically separated from magnesium oxide and citric acid prior to dispensing and is mixed at the time of administration.
    Type: Application
    Filed: June 9, 2020
    Publication date: December 24, 2020
    Inventors: Parthasaradhi Reddy BANDI, Khadgapathi PODILE, Sunil Deviprasad TIWARI, Vijay NASARE, Prakash SHETIYA, Patchigolla Satyanarayana RAO, Chidara Ravi Chandra GUPTA
  • C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitors
    Patent number: 10669305
    Abstract: The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R1, R2, R3, W, J and X are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: June 2, 2020
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Rathnakar Reddy Kura, David Krupadanam Gazula Levi, Panduranga Reddy Adulla, Bhaskar Reddy Kasireddy, Carl Thomas Wild, David Eugene Martin, Theodore John Nitz
  • STABLE ORAL LIQUID COMPOSITIONS OF ENALAPRIL
    Publication number: 20190336478
    Abstract: The present invention relates to pharmaceutical compositions of enalapril, particularly stable oral liquid compositions comprising enalapril, one or more buffering agents and at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: May 3, 2019
    Publication date: November 7, 2019
    Applicant: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy BANDI, Khadgapathi PODILE, Sunil Deviprasad TIWARI, Prakash SHETIYA, Satyanarayana Rao PATCHIGOLLA, Ravi Chandra Gupta CHIDARA
  • STABLE BILAYER TABLET COMPOSITIONS
    Publication number: 20190290588
    Abstract: The invention relates to stable bilayer tablet compositions comprising empagliflozin, linagliptin and pharmaceutically acceptable excipients which show no incompatibilities and the compositions having good stability and superior dissolution profile.
    Type: Application
    Filed: August 14, 2018
    Publication date: September 26, 2019
    Inventors: Parthasaradhi Reddy BANDI, Khadgapathi Podile, Sunil Deviprasad Tiwari, Srinivasa Rao Gella
  • C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
    Patent number: 10370405
    Abstract: The invention relates to C-3 novel triterpenone with C-28 amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases (formula 1).
    Type: Grant
    Filed: March 12, 2016
    Date of Patent: August 6, 2019
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Rathnakar Reddy Kura, David Krupadanam Gazula Levi, Panduranga Reddy Adulla, Eswara Rao Bammidi, Bhaskar Reddy Kasireddy, Sudhakar Neela, Carl Thomas Wild, David Eugene Martin, Theodore John Nitz
  • C-3 NOVEL TRITERPENONE WITH C-28 UREA DERIVATIVES AS HIV INHIBITORS
    Publication number: 20180305398
    Abstract: The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R1, R2, R3, W, J and X are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.
    Type: Application
    Filed: October 12, 2016
    Publication date: October 25, 2018
    Inventors: Parthasaradhi Reddy BANDI, Rathnakar Reddy KURA, David Krupadanam GAZULA LEVI, Panduranga Reddy ADULLA, Bhaskar Reddy KASIREDDY, Carl Thomas Wild, David Eugene Martin, Theodore John Nitz
  • PROCESS FOR THE PREPARATION OF LOMITAPIDE
    Publication number: 20180291773
    Abstract: The present invention relates to a process for preparing Lomitapide or its pharmaceutically acceptable salt thereof having high purity with acceptable levels of impurities.
    Type: Application
    Filed: June 14, 2018
    Publication date: October 11, 2018
    Inventors: Parthasaradhi Reddy Bandi, Rathnakar Reddy Kura, Vamsi Krishna Bandi, Mukunda Reddy Jambula
  • C-3 NOVEL TRITERPENONE WITH C-28 AMIDE DERIVATIVES AS HIV INHIBITORS
    Publication number: 20180237472
    Abstract: The invention relates to C-3 novel triterpenone with C-28 amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases (formula 1).
    Type: Application
    Filed: March 12, 2016
    Publication date: August 23, 2018
    Inventors: Parthasaradhi Reddy BANDI, Rathnakar Reddy KURA, David Krupadanam GAZULA LEVI, Panduranga Reddy ADULLA, Eswara Rao BAMMIDI, Bhaskar Reddy KASIREDDY, Sudhakar NEELA, Carl Thomas WILD, David Eugene MARTIN, Theodore John NITZ
  • PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
    Publication number: 20180064653
    Abstract: The present invention relates to solid oral dosage forms of Dimethyl fumarate. More specifically, the present invention relates to delayed release compositions of Dimethyl fumarate and process for their preparation.
    Type: Application
    Filed: March 14, 2016
    Publication date: March 8, 2018
    Inventors: Parthasaradhi Reddy BANDI, Khadgapathi PODILE, Naresh ANAPARTY
  • Betulinic proline imidazole derivatives as HIV inhibitors
    Patent number: 9868758
    Abstract: The present invention relates to novel betulinic proline imidazole derivatives and related compounds, compositions useful for therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: January 16, 2018
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Rathnakar Reddy Kura, Panduranga Reddy Adulla, David Krupadanam Gazula Levi, Eswara Rao Bammidi, Ranga Reddy, Carl Thomas Wild, David Eugene Martin, Theodore John Nitz
  • NOVEL BETULINIC PROLINE IMIDAZOLE DERIVATIVES AS HIV INHIBITORS
    Publication number: 20170129917
    Abstract: The present invention relates to novel betulinic proline imidazole derivatives and related compounds, compositions useful for therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Application
    Filed: June 29, 2015
    Publication date: May 11, 2017
    Inventors: Parthasaradhi Reddy Bandi, Rathnakar Reddy Kura, Panduranga Reddy Adulla, David Krupadanam Gazula Levi, Eswara Rao Bammidi, Ranga Reddy